20:45:30 EST Sun 08 Feb 2026
Enter Symbol
or Name
USA
CA



Shell Summary for Oct. 13, 2015

2015-10-13 20:59 ET - Market Summary

This item is part of Stockwatch's value added news feed and is only available to Stockwatch subscribers.

Here is a sample of this item:

by Stockwatch Business Reporter

The TSX Venture Exchange added 1.12 points to 553.38 Tuesday. Praveen Varshney's halted eight-year-old capital pool shell, Genview Capital Corp. (GVW), will ask shareholders at a Nov. 23 meeting to approve its acquisition of Dharma Distributors Ltd., doing business as Hempco Canada Superfoods. The shell seems confident this qualifying transaction will close, having already submitted a draft filing statement to the exchange.

Genview plans to roll back 1:2, leaving it with 4.2 million postconsolidated shares, and then issue 20 million postconsolidated shares to Dharma's two shareholders, Charles Holmes and his sister, Angela Holmes. Dharma is a manufacturer and distributor of hemp food products such as bulk hemp seeds, hemp protein powder and hemp oil. It also recently launched a line of retail products under the brand name PlanetHemp. The company has not provided audited financials just yet, but according to Hempco's marketing material, it projects revenue of $4.5-million this year and claims to be "already generating profits for shareholders," all two of them. There will be more shareholders shortly. Dharma says it has already closed a $225,000 first tranche convertible note financing and it expects to close a second tranche of up to $500,000. The notes will convert into postconsolidated shares of Genview when the QT closes. Genview is also trying to round up investors for a $1.2-million private placement of three million shares at 40 cents in connection with closing the QT.

The remainder is available to Stockwatch subscribers.
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

© 2026 Canjex Publishing Ltd. All rights reserved.


Reader Comments - Comments are open to paying subscribers of Stockwatch and unmoderated, although libelous remarks, obscene language and impersonations may be deleted. Opinions expressed do not necessarily reflect the views of Stockwatch.
For information regarding Canadian libel law, please view the University of Ottawa's FAQ regarding Defamation and SLAPPs.


Comments for this item are closed